Cancer cells compress intratumour vessels
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The delivery of therapeutic drugs to solid tumours may be impaired by structural and functional abnormalities in blood and lymphatic vessels. Here we provide evidence that proliferating cancer cells cause intratumour vessels to compress and collapse. By reducing this compressive mechanical force and opening vessels, cytotoxic cancer treatments have the potential to increase blood perfusion, thereby improving drug delivery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This results in uneven blood flow within the tumor, generating regions of chronic or intermittent hypoxia and regions of enhanced permeability and increased interstitial pressure, which can result in compression of tumor vessels and poor vascular perfusion, hampering drug delivery [27].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [27]
In the citing paper
“It enhances tumor cell proliferation and builds up a transport barrier to drug delivery, greatly lowering the efficacy of anticancer drugs and therapies.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
In the citing paper
“Elevated extracellular stresses have been observed in many tumors[170][171][172][173][174][175][176][177][178].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [171]
Citations
Cites
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,529
Self-citationLymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967
Self-citationSolid stress inhibits the growth of multicellular tumor spheroids
Helmlinger, G., Netti, P. A., Lichtenbeld, H. C., Melder, R. J., & Jain, R. K. (1997) · Nature Biotechnology · doi:10.1038/nbt0897-778 · Cited by 859
Self-citationMolecular mechanisms of lymphangiogenesis in health and disease
Alitalo, K., & Carmeliet, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00051-x · Cited by 734
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Self-citation(1999) · PubMed · Cited by 348
Self-citationThe Second Valve System in Lymphatics
Schmid-Schönbein, G. W. (2003) · Lymphatic Research and Biology · doi:10.1089/15396850360495664 · Cited by 113
Solid stress facilitates spheroid formation: potential involvement of hyaluronan
Koike, C., McKee, T. D., Pluen, A., Ramanujan, S., Burton, K., Munn, L. L., Boucher, Y., & Jain, R. K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600158 · Cited by 83
Self-citationImproved microcirculation in irradiated tumours
Reinhold, H. S. (1971) · European Journal of Cancer (1965) · doi:10.1016/0014-2964(71)90069-7 · Cited by 71
Arbiser, J. L., Raab, G., Rohan, R. M., Paul, S., Hirschi, K. K., Flynn, E. A., Price, E. R., Fisher, D. E., Cohen, C., & Klagsbrun, M. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65171-1 · Cited by 36
Research works printed but not linked: 2
- Boucher, Y. & Jain, R. K. Cancer Res. 52, 5110–5114 (1992).
- Griffon-Etienne, G., Boucher, Y., Brekken, C., Suit, H. D. & Jain, R. K. Cancer Res. 59, 3776–3782 (1999).
Cited by
Items 101–200 of 859
Designing nanomedicine for immuno-oncology
Jiang, W., von Roemeling, C. A., Chen, Y., Qie, Y., Liu, X., Chen, J., & Kim, B. Y. S. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0029 · Cited by 229
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Photoswitchable nanoparticles for in vivo cancer chemotherapy
Tong, R., Chiang, H. H., & Kohane, D. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315336110 · Cited by 227
“However, the EPR effect is often compromised by the tumor microenvironment (9–11): compressed intratumoral blood and lymphatic vessels can hinder the delivery of blood-borne therapeutic agents (12, 13), while the dense collagen-rich extracellular matrix can retard the diffusion of nanomedicines within the tumor (14, 1…”
BackgroundTumor cell migration in complex microenvironments
Polacheck, W. J., Zervantonakis, I. K., & Kamm, R. D. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1115-1 · Cited by 225
“High compressive stress within tumors, which can collapse intratumoral blood vessels [142], can also influence the invasive properties of cells within the tumor by creating hypoxia and high interstitial pressure.”
Durfee, P. N., Lin, Y.-S., Dunphy, D. R., Muñiz, A. J., Butler, K. S., Humphrey, K. R., Lokke, A. J., Agola, J. O., Chou, S. S., Chen, I.-M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b02819 · Cited by 219
“and negatively charged vesicles onto glass as a function of pH (3-12) and ionic strength (0-90”
BackgroundApplications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration
Li, Z., Shan, X., Chen, Z., Gao, N., Zeng, W., Zeng, X., & Mei, L. (2021) · Advanced Science · doi:10.1002/advs.202002589 · Cited by 218
Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment
Wu, P., Gao, W., Su, M., Nice, E. C., Zhang, W., Lin, J., & Xie, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641469 · Cited by 209
The biology and mathematical modelling of glioma invasion: a review
Alfonso, J. C. L., Talkenberger, K., Seifert, M., Klink, B., Hawkins-Daarud, A., Swanson, K. R., Hatzikirou, H., & Deutsch, A. (2017) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0490 · Cited by 209
Nanotechnology platforms and physiological challenges for cancer therapeutics
Kim, K. Y. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.002 · Cited by 201
“[28] Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK.”
BackgroundYasuda, H. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.026 · Cited by 198
Oudin, M. J., & Weaver, V. M. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030817 · Cited by 196
“…include high tumor solid stress that reflects the tumor genotype and is promoted by the expanding tumor cell mass, the elevated interstitial pressure, and the resistance exerted by the surrounding stiffened, fibrotic ECM (Padera et al. 2004; Paszek et al. 2005; Willipinski-Stapelfeldt et al. 2005).”
BackgroundMechanobiology of Tumor Growth
Chaudhuri, P. K., Low, B. C., & Lim, C. T. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00042 · Cited by 192
Nano‐Graphene Oxide: A Potential Multifunctional Platform for Cancer Therapy
Gonçalves, G., Vila, M., Portolés, M., Vallet‐Regi, M., Gracio, J., & Marques, P. A. A. P. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300023 · Cited by 192
Taghian, A. G., Abi-Raad, R., Assaad, S. I., Casty, A., Ancukiewicz, M., Yeh, E., Molokhia, P., Attia, K., Sullivan, T., Kuter, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.119 · Cited by 192
A critical review of lipid-based nanoparticles for taxane delivery
Feng, L., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.006 · Cited by 191
“Studies have shown that lymphatic systems inside solid tumors are dysfunctional.[35, 36] The absence of lymphatic drainage causes prolonged retention of macromolecules once they extravasate the leaky vasculature and locate inside the tumors.”
BackgroundExtravasation of polymeric nanomedicines across tumor vasculature
Danquah, M. K., Zhang, X. A., & Mahato, R. I. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.005 · Cited by 188
Ghosh, K., Thodeti, C. K., Dudley, A. C., Mammoto, A., Klagsbrun, M., & Ingber, D. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800835105 · Cited by 188
“Tumor stroma is stiffer than normal ECM, likely due to high interstitial pressure, increased fibrillar collagen deposition in capsular regions, and physical stress from the expanding solid tumor mass (18).”
BackgroundReview of optical breast imaging and spectroscopy
Grosenick, D., Rinneberg, H., Cubeddu, R., & Taroni, P. (2016) · Journal of Biomedical Optics · doi:10.1117/1.jbo.21.9.091311 · Cited by 187
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Davodabadi, F., Sajjadi, S. F., Sarhadi, M., Mirghasemi, S., Nadali Hezaveh, M., Khosravi, S., Kamali Andani, M., Cordani, M., Basiri, M., & Ghavami, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176013 · Cited by 184
Linking cell mechanical memory and cancer metastasis
Cambria, E., Coughlin, M. F., Floryan, M. A., Offeddu, G. S., Shelton, S. E., & Kamm, R. D. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00656-5 · Cited by 183
Huber, P. E., Bischof, M., Jenne, J., Heiland, S., Peschke, P., Saffrich, R., Gröne, H.-J., Debus, J., Lipson, K. E., & Abdollahi, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1668 · Cited by 185
Scaling rules for diffusive drug delivery in tumor and normal tissues
Baish, J. W., Stylianopoulos, T., Lanning, R. M., Kamoun, W. S., Fukumura, D., Munn, L. L., & Jain, R. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018154108 · Cited by 182
Self-citationRole of vascular normalization in benefit from metronomic chemotherapy
Mpekris, F., Baish, J. W., Stylianopoulos, T., & Jain, R. K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700340114 · Cited by 178
“An analysis of published experimental data (51, 52) reveals that the relative decrease in the diameter of tumor blood vessels is inversely proportional to cell density (SI Appendix, Fig.”
BackgroundMethodSelf-citationHuang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176
“In addition, the proliferating cancer cells in the center of the tumor tissue will form excessive pressure and compress the blood vessels and lymphatic vessels, leading to vascular collapse [88,94,95].”
BackgroundReengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 175
“In vivo studies showing that killing proliferating cells in tumors could decompress vessels (Griffon-Etienne et al. 1999; Padera et al. 2004) indicated that solid tumor components play a key role in vascular collapse.”
BackgroundSelf-citationThe exit of nanoparticles from solid tumours
Nguyen, L. N. M., Lin, Z. P., Sindhwani, S., MacMillan, P., Mladjenovic, S. M., Stordy, B., Ngo, W., & Chan, W. C. W. (2023) · Nature Materials · doi:10.1038/s41563-023-01630-0 · Cited by 172
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
DuFort, C. C., DelGiorno, K. E., Carlson, M. A., Osgood, R. J., Zhao, C., Huang, Z., Thompson, C. B., Connor, R. J., Thanos, C. D., Scott Brockenbrough, J., et al. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.03.040 · Cited by 171
“Solid stress may also contribute to total tissue pressure, of course, particularly in the setting of the hypercellular tumors more commonly observed with transplanted cancer cell lines (67).”
BackgroundIntermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours
Toffoli, S., & Michiels, C. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06454.x · Cited by 169
The Solid Mechanics of Cancer and Strategies for Improved Therapy
Stylianopoulos, T. (2017) · Journal of Biomechanical Engineering · doi:10.1115/1.4034991 · Cited by 169
“Proliferating cancer cells can also exert forces on other cells and surrounding structures [31,32].”
BackgroundMorphologic Instability and Cancer Invasion
Cristini, V., Frieboes, H. B., Gatenby, R., Caserta, S., Ferrari, M., & Sinek, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0852 · Cited by 163
“These pressures can be different within the tumor tissue (2, 4, 44 ).”
BackgroundMethodImaging angiogenesis and the microenvironment
FUKUMURA, D., & JAIN, R. K. (2008) · APMIS · doi:10.1111/j.1600-0463.2008.01148.x · Cited by 162
“Proliferating tumor cells in a confined space create mechanical stress (solid stress) which compresses intratumor lymphatic vessels (14).”
BackgroundSelf-citationLiu, Y., Bai, L., Guo, K., Jia, Y., Zhang, K., Liu, Q., Wang, P., & Wang, X. (2019) · Theranostics · doi:10.7150/thno.33183 · Cited by 158
Dieterich, L. C., Tacconi, C., Ducoli, L., & Detmar, M. J. (2022) · Physiological Reviews · doi:10.1152/physrev.00039.2021 · Cited by 179
Shim, M. K., Yang, S., Sun, I., & Kim, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114177 · Cited by 171
Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery
Stapleton, S., Jaffray, D. A., & Milosevic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.021 · Cited by 168
Mechanical Forces in Tumor Angiogenesis
Zanotelli, M. R., & Reinhart-King, C. A. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-95294-9_6 · Cited by 153
Peritumor Lymphatics Induced by Vascular Endothelial Growth Factor-C Exhibit Abnormal Function
Isaka, N., Padera, T. P., Hagendoorn, J., Fukumura, D., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0752 · Cited by 153
“In concert with our previous findings (3, 6, 17 ), we found a lack of functional lymphatics in B16F10-VEGF-C or B16F10-MT tumors after intratumor injections of Evan’s blue dye or ferritin.”
MethodResultSelf-citationWong, S. Y., Haack, H., Crowley, D., Barry, M., Bronson, R. T., & Hynes, R. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0901 · Cited by 153
“Other studies have suggested that intratumoral lymphatics may be nonfunctional (17, 22, 23 ), or display abnormal function at the periphery (24), implying that lymphangiogenesis plays little role in facilitating primary tumor dissemination.”
BackgroundModulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
Zhang, B., Hu, Y., & Pang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00952 · Cited by 152
“First, limited interstitial volume plus high stromal fraction and large matrix molecules result in a dense network (Padera et al., 2004), effectively reducing blood flow and limiting convection of nanomedicine.”
BackgroundReleasing Pressure in Tumors: What Do We Know So Far and Where Do We Go from Here? A Review
Ariffin, A. B., Forde, P. F., Jahangeer, S., Soden, D. M., & Hinchion, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3696 · Cited by 150
Exploring the Tumor Microenvironment with Nanoparticles
Miao, L., & Huang, L. (2015) · Cancer Treatment and Research · doi:10.1007/978-3-319-16555-4_9 · Cited by 144
“Moreover, stroma cells compress intratumoral blood and lymphatic vessels, which consequently impairs blood flow, leading to blood stasis, loss of function, and further inhibition of NP penetration [70].”
BackgroundBiomechanical regulation of cell orientation and fate
Lopez, J. I., Mouw, J. K., & Weaver, V. M. (2008) · Oncogene · doi:10.1038/onc.2008.348 · Cited by 145
“For instance, force appears to exert a profound effect on apoptosis resistance and likely alters the efficacy of drug delivery to tumors (Chen et al., 1997; Numaguchi et al., 2003; Padera et al., 2004).”
BackgroundInterstitial Fluid Pressure in Tumors: Therapeutic Barrier and Biomarker of Angiogenesis
Lunt, S. J., Fyles, A., Hill, R. P., & Milosevic, M. (2008) · Future Oncology · doi:10.2217/14796694.4.6.793 · Cited by 145
Bernhard, H., Neudorfer, J., Gebhard, K., Conrad, H., Hermann, C., Nährig, J., Fend, F., Weber, W., Busch, D. H., & Peschel, C. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0355-7 · Cited by 152
“The abnormal tumor vasculature, including increased expression of vascular endothelial factor and impaired blood/lymphatic Xow can contribute to the failure of T cells to leave the vessels and penetrate into the tumor tissue [5, 28 ].”
BackgroundDuFort, C. C., DelGiorno, K. E., & Hingorani, S. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.040 · Cited by 144
CHRONIC EFFECTS OF MECHANICAL FORCE ON AIRWAYS
Tschumperlin, D. J., & Drazen, J. M. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.072304.113102 · Cited by 143
Small Molecules for Active Targeting in Cancer
Kue, C. S., Kamkaew, A., Burgess, K., Kiew, L. V., Chung, L. Y., & Lee, H. B. (2016) · Medicinal Research Reviews · doi:10.1002/med.21387 · Cited by 141
“The first two radiolabeled small-molecule ligands in this series were benzamide analogues [18F]3c (26) and [18F]3f (27).”
BackgroundReview of the Pericyte during Angiogenesis and its Role in Cancer and Diabetic Retinopathy
Hall, A. P. (2006) · Toxicologic Pathology · doi:10.1080/01926230600936290 · Cited by 160
Millard, M., Yakavets, I., Zorin, V., Kulmukhamedova, A., Marchal, S., & Bezdetnaya, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146927 · Cited by 141
“With the tumor growth, vessel compressions due to the development of proliferating cells or other stromal components contribute to the enhancement of blood flow and intravascular pressure irregularities.(12,13) These parameters strongly disrupt oxygen, nutrient and blood-borne molecule delivery to tumor tissues.”
Rofstad, E. K., Galappathi, K., & Mathiesen, B. S. (2014) · Neoplasia · doi:10.1016/j.neo.2014.07.003 · Cited by 154
Papageorgis, P., Polydorou, C., Mpekris, F., Voutouri, C., Agathokleous, E., Kapnissi-Christodoulou, C. P., & Stylianopoulos, T. (2017) · Scientific Reports · doi:10.1038/srep46140 · Cited by 138
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Thomas, O. S., & Weber, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00415 · Cited by 159
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors
Belyaev, I. B., Griaznova, O. Y., Yaremenko, A. V., Deyev, S. M., & Zelepukin, I. V. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115550 · Cited by 161
“This retention has largely been attributed to impaired lymphatic drainage, due to the collapse of lymphatic vessels or the absence of functional lymphatics far from the tumor margin [7,43].”
Duda, D. G., Jain, R. K., & Willett, C. G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3985 · Cited by 138
Self-citationMartin, J. D., Panagi, M., Wang, C., Khan, T. T., Martin, M. R., Voutouri, C., Toh, K., Papageorgis, P., Mpekris, F., Polydorou, C., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b07865 · Cited by 137
Hagendoorn, J., Tong, R., Fukumura, D., Lin, Q., Lobo, J., Padera, T. P., Xu, L., Kucherlapati, R., & Jain, R. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2655 · Cited by 136
“This abnormality can result from an imbalance in molecular factors regulating vessel growth and maturation as well as from compressive mechanical forces generated by proliferating neoplastic cells (5, 6).”
BackgroundResultSelf-citationLeung, C. S., Yeung, T.-L., Yip, K.-P., Wong, K.-K., Ho, S. Y., Mangala, L. S., Sood, A. K., Lopez-Berestein, G., Sheng, J., Wong, S. T. C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95200 · Cited by 132
Jain, R. K., & Carmeliet, P. (2012) · Cell · doi:10.1016/j.cell.2012.05.025 · Cited by 151
Self-citationAngiogenesis in metastatic colorectal cancer and the benefits of targeted therapy
Sun, W. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-63 · Cited by 129
“The endothelial layer is irregular and contains spaces that contribute to the leakiness of tumor vessels [9], proliferating tumor cells cause compression of vessels [10], and interstitial pressure is increased [11].”
BackgroundLumeNEXT: A Practical Method to Pattern Luminal Structures in ECM Gels
Jiménez‐Torres, J. A., Peery, S. L., Sung, K. E., & Beebe, D. J. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500608 · Cited by 132
Real-time Imaging of Tumor-Cell Shedding and Trafficking in Lymphatic Channels
Hayashi, K., Jiang, P., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., Moossa, A. R., Bouvet, M., & Hoffman, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1237 · Cited by 131
“An imbalance in molecular factors regulating vessel growth and maturation as well as compressive mechanical forces generated by proliferating cancer cells could lead to vessel abnormality (19, 20).”
BackgroundKansız, S., & Elçin, Y. M. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102930 · Cited by 143
Sen, A., Capitano, M. L., Spernyak, J. A., Schueckler, J. T., Thomas, S., Singh, A. K., Evans, S. S., Hylander, B. L., & Repasky, E. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4482 · Cited by 130
The Fluid Mechanics of Cancer and Its Therapy
Koumoutsakos, P., Pivkin, I., & Milde, F. (2013) · Annual Review of Fluid Mechanics · doi:10.1146/annurev-fluid-120710-101102 · Cited by 129
“Tumors exert mechanical stresses on the surrounding blood and lymphatic vessels (Padera et al. 2004, Young 1959, Stylianopoulos et al. 2012), further hindering hematogenous drug transport.”
BackgroundTranscytosis of Nanomedicine for Tumor Penetration
Liu, Y., Huo, Y., Yao, L., Xu, Y., Meng, F., Li, H., Sun, K., Zhou, G., Kohane, D. S., & Tao, K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03211 · Cited by 127
Falagan-Lotsch, P., Grzincic, E. M., & Murphy, C. J. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00591 · Cited by 138
Silvestri, V. L., Henriet, E., Linville, R. M., Wong, A. D., Searson, P. C., & Ewald, A. J. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1564 · Cited by 125
“Previous work suggested that tumors passively create stress on vessels due to growth in a confined space (53, 54).”
BackgroundMechanisms of lymphatic metastasis in human colorectal adenocarcinoma
Royston, D. J., & Jackson, D. G. (2009) · The Journal of Pathology · doi:10.1002/path.2517 · Cited by 129
Modeling Growth in Biological Materials
Jones, G. W., & Chapman, S. J. (2012) · SIAM Review · doi:10.1137/080731785 · Cited by 140
Munn, L. L., & Padera, T. P. (2014) · Microvascular Research · doi:10.1016/j.mvr.2014.06.006 · Cited by 135
Self-citationIn-vivo photoacoustic microscopy of nanoshell extravasation from solid tumor vasculature
Li, M., Wang, J. C., Schwartz, J. A., Gill‐Sharp, K. L., Stoica, G., & Wang, L. V. (2009) · Journal of Biomedical Optics · doi:10.1117/1.3081556 · Cited by 124
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A
Mura, M., Swain, R. K., Zhuang, X., Vorschmitt, H., Reynolds, G. M., Durant, S., Beesley, J. F. J., Herbert, J. M. J., Sheldon, H., Andre, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.233 · Cited by 139
“Tumors also show nutrient (for example, glucose) deprivation, acidic extracellular pH, high interstitial pressure (Helmlinger et al., 1997), excess of pro-angiogenic activity (for example, vascular endothelial (VE) growth factor) and increased mechanical compression (Padera et al., 2004).”
BackgroundRemodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
Gkretsi, V., Stylianou, A., Papageorgis, P., Polydorou, C., & Stylianopoulos, T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00214 · Cited by 123
Voutouri, C., Polydorou, C., Papageorgis, P., Gkretsi, V., & Stylianopoulos, T. (2016) · Neoplasia · doi:10.1016/j.neo.2016.10.001 · Cited by 139
“These stresses can also compress intratumoral blood and lymphatic vessels and thus cause hypoxia and hypoperfusion [1,17,18].”
BackgroundLymphatic function and immune regulation in health and disease
Liao, S., & Padera, T. P. (2013) · Lymphatic Research and Biology · doi:10.1089/lrb.2013.0012 · Cited by 122
“Interstitial fluid pressure in cancer is frequently increased as a result of the hyperpermeable tumor blood vasculature and the lack of lymphatic function from inside tumors.(108) Interstitial hypertension in tumors increases interstitial flow leaving the tumor, which has been positively correlated with cancer cell di…”
BackgroundSelf-citationModeling Morphogenesis and Oncogenesis in Three-Dimensional Breast Epithelial Cultures
Hebner, C., Weaver, V. M., & Debnath, J. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151526 · Cited by 122
Wong, H. K., Lahdenranta, J., Kamoun, W. S., Chan, A. W., McClatchey, A. I., Plotkin, S. R., Jain, R. K., & di Tomaso, E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3107 · Cited by 129
“One of the most important forms of nerve edema is induced by external compression, similar to the one that can be induced by tumor growth (40).”
BackgroundSelf-citationUltrasound and microbubbles to beat barriers in tumors: Improving delivery of nanomedicine
Snipstad, S., Vikedal, K., Maardalen, M., Kurbatskaya, A., Sulheim, E., & Davies, C. D. L. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113847 · Cited by 127
Hypoxia and the phenomenon of immune exclusion
Pietrobon, V., & Marincola, F. M. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02667-4 · Cited by 119
Vascular Normalization: A New Window Opened for Cancer Therapies
Yang, T., Xiao, H., Liu, X., Wang, Z., Zhang, Q., Wei, N., & Guo, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719836 · Cited by 141
Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake
Matuszewska, K., Pereira, M., Petrik, D., Lawler, J., & Petrik, J. (2021) · Cancers · doi:10.3390/cancers13174444 · Cited by 134
“The etiology of IFP elevation is multifactorial and involves high vascular permeability and mechanical compression of lymphatic blood vessels [54,55].”
BackgroundBystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
Dachs, G. U., Hunt, M. A., Syddall, S. P., Singleton, D. C., & Patterson, A. V. (2009) · Molecules · doi:10.3390/molecules14114517 · Cited by 123
“The situation is compounded by a tumour’s poorly organised vascular architecture [29], irregular blood flow [30] and compression of blood and lymphatic vessels by tumour cells, creating additional areas of low perfusion and temporary hypoxia [31].”
BackgroundStructural ECM components in the premetastatic and metastatic niche
Høye, A. M., & Erler, J. T. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00326.2015 · Cited by 114
Mpekris, F., Angeli, S. I., Pirentis, A. P., & Stylianopoulos, T. (2015) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-015-0682-0 · Cited by 123
Zhang, J., Liu, H., Tong, H., Wang, S., Yang, Y., Liu, G., & Zhang, W. (2017) · Contrast Media & Molecular Imaging · doi:10.1155/2017/7064120 · Cited by 123
Nanomedicine Penetration to Tumor: Challenges, and Advanced Strategies to Tackle This Issue
Munir, M. U. (2022) · Cancers · doi:10.3390/cancers14122904 · Cited by 121
“Second, in the middle of tumor tissue, substantial stress is exerted by proliferating cancer cells resulting in the compression of lymphatic and blood vessels, resulting in vessel failure [25] and causing functional lymphatic and blood vessels to be concentrated at the tumor sides [26].”
BackgroundEvaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound
Guibal, A., Boularan, C., Bruce, M. F., Vallin, M., Pilleul, F., Walter, T., Scoazec, J., Boublay, N., Dumortier, J., & Lefort, T. (2012) · European Radiology · doi:10.1007/s00330-012-2692-y · Cited by 113
“The elevation in elasticity values found with SWE likely originate from several factors, including changes in vascular and lymphatic permeability, along with changes in collagen deposition and cellular architecture [34].”
BackgroundTumor Interstitial Fluid Formation, Characterization, and Clinical Implications
Wagner, M., & Wiig, H. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00115 · Cited by 131
“Other factors contributing to the high tumor Pif would be intratumoral blood vessel compression due to solid stress due to growth (54), and direct effects of growth factors such as PDGF, TGF-β, and VEGF (40).”
BackgroundUltrasound in tumor immunotherapy: Current status and future developments
Ho, Y.-J., Li, J.-P., Fan, C., Liu, H.-L., & Yeh, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.023 · Cited by 119
Voutouri, C., Mpekris, F., Papageorgis, P., Odysseos, A. D., & Stylianopoulos, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104717 · Cited by 126
“e, the stresses of the solid phase of a tumor) shape the tumor microenvironment by at least two ways: directly by compressing cancer and stromal cells and indirectly by compressing intratumor blood and lymphatic vessels [1–4].”
BackgroundThe role of tumor microenvironment in prostate cancer bone metastasis
Morrissey, C., & Vessella, R. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21214 · Cited by 109
“CD31, CD171, and developmental endothelial locus-1 (Del-1) adhesion molecules are known to be ligands of avb3 and avb5 as well as components of the ECM [Penta et al., 1999; Voura et al., 2001; Aoka et al., 2002].”
BackgroundPadera, T. P., Kuo, A. H., Hoshida, T., Liao, S., Lobo, J., Kozak, K. R., Fukumura, D., & Jain, R. K. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0182 · Cited by 109
Self-citationLinke, J. A., Munn, L. L., & Jain, R. K. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00745-z · Cited by 132
Self-citationHofmann, M., Guschel, M., Bernd, A., Bereiter-Hahn, J., Kaufmann, R., Tandi, C., Wiig, H., & Kippenberger, S. (2006) · Neoplasia · doi:10.1593/neo.05469 · Cited by 106
“Furthermore, enhanced TIFP and compressive forces generated by proliferating tumor cells may lead to a permanent mechanical stretching of the tumor cortex [36].”
BackgroundEndothelial Nitric Oxide Synthase Regulates Microlymphatic Flow via Collecting Lymphatics
Hagendoorn, J., Padera, T. P., Kashiwagi, S., Isaka, N., Noda, F., Lin, M. I., Huang, P. L., Sessa, W. C., Fukumura, D., & Jain, R. K. (2004) · Circulation Research · doi:10.1161/01.res.0000135549.72828.24 · Cited by 104
Self-citationOvercoming tumor microenvironment obstacles: Current approaches for boosting nanodrug delivery
Wang, X., Zhang, H., Chen, X., Wu, C., Ding, K., Sun, G., Luo, Y., & Xiang, D. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.043 · Cited by 103
Targeting fibronectins of glioma extracellular matrix by CLT1 peptide-conjugated nanoparticles
Zhang, B., Shen, S., Liao, Z., Shi, W., Wang, Y., Zhao, J., Hu, Y., Yang, J., Chen, J., Mei, H., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.046 · Cited by 103
Francis, D. M., & Thomas, S. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.011 · Cited by 107
“However, as the result of extracellular matrix and vascular remodeling within the tumor microenvironment, lymphatic transport in solid tumors is significantly attenuated [103,104], which has the potential to undermine a lymphatic mediated drug delivery strategy to tumor-draining lymph nodes via i.”
BackgroundMammary tumour cells remodel the bone marrow vascular microenvironment to support metastasis
Yip, R. K. H., Rimes, J. S., Capaldo, B. D., Vaillant, F., Mouchemore, K. A., Pal, B., Chen, Y., Surgenor, E. E., Murphy, A. J., Anderson, R. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26556-6 · Cited by 125
Esser, A. T., Smith, K. C., Gowrishankar, T. R., & Weaver, J. C. (2007) · Technology in Cancer Research & Treatment · doi:10.1177/153303460700600402 · Cited by 107
Metadata
- Authors
- Padera, T. P., Stoll, B. R., Tooredman, J. B., Capen, D., Tomaso, E. D., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Jain, Rakesh K.
- Venue
- Nature
- Published
- 2004-02-19
- Volume
- 427
- Issue
- 6976
- Pages
- 695-695
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2014282546
- Cited by
- 857
- References
- 10
- Citations by year
- 2026: 28 · 2025: 48 · 2024: 40 · 2023: 47 · 2022: 39 · 2021: 44 · 2020: 48 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 48 · 2015: 32 · 2014: 36 · 2013: 39 · 2012: 42
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor vasculature, tumor cell proliferation, vascular collapse, mechanical forces, lymphatic vessels, cytotoxic chemotherapy
- MeSH terms
- Animals, Cell Division, Diphtheria Toxin, Humans, Neoplasm Transplantation, Neoplasms, Transplantation, Heterologous, Reperfusion, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.